As of 2025-12-22, the Relative Valuation of Chemours Co (CC) is (9.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.82 USD, the upside of Chemours Co based on Relative Valuation is -176.6%.
The range of the Relative Valuation is (27.68) - 16.82 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 16.8x | 14.4x |
| Forward P/E multiples | 10.4x - 14.0x | 11.5x |
| Fair Price | (27.68) - 16.82 | (9.05) |
| Upside | -334.2% - 42.3% | -176.6% |
| Date | P/E |
| 2025-12-19 | -5.32 |
| 2025-12-18 | -5.34 |
| 2025-12-17 | -5.23 |
| 2025-12-16 | -5.26 |
| 2025-12-15 | -5.30 |
| 2025-12-12 | -5.83 |
| 2025-12-11 | -5.92 |
| 2025-12-10 | -5.88 |
| 2025-12-09 | -5.58 |
| 2025-12-08 | -5.49 |
| 2025-12-05 | -5.72 |
| 2025-12-04 | -5.64 |
| 2025-12-03 | -5.83 |
| 2025-12-02 | -5.75 |
| 2025-12-01 | -5.78 |
| 2025-11-28 | -5.76 |
| 2025-11-26 | -5.61 |
| 2025-11-25 | -5.55 |
| 2025-11-24 | -5.18 |
| 2025-11-21 | -4.97 |
| 2025-11-20 | -4.72 |
| 2025-11-19 | -4.82 |
| 2025-11-18 | -4.92 |
| 2025-11-17 | -5.06 |
| 2025-11-14 | -5.35 |
| 2025-11-13 | -5.52 |
| 2025-11-12 | -5.68 |
| 2025-11-11 | -5.69 |
| 2025-11-10 | -5.74 |
| 2025-11-07 | -5.63 |
| 2025-11-06 | -5.28 |
| 2025-11-05 | -5.42 |
| 2025-11-04 | -5.50 |
| 2025-11-03 | -5.71 |
| 2025-10-31 | -6.03 |
| 2025-10-30 | -5.91 |
| 2025-10-29 | -6.19 |
| 2025-10-28 | -6.23 |
| 2025-10-27 | -6.30 |
| 2025-10-24 | -6.32 |
| 2025-10-23 | -6.25 |
| 2025-10-22 | -6.09 |
| 2025-10-21 | -6.01 |
| 2025-10-20 | -5.99 |
| 2025-10-17 | -5.81 |
| 2025-10-16 | -6.19 |
| 2025-10-15 | -6.49 |
| 2025-10-14 | -6.19 |
| 2025-10-13 | -6.05 |
| 2025-10-10 | -5.65 |